These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17972121)

  • 21. Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: chest radiographic appearances.
    Gross GW; Greenspan JS; Fox WW; Rubenstein SD; Wolfson MR; Shaffer TH
    Radiology; 1995 Mar; 194(3):717-20. PubMed ID: 7862968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perfluorochemical rescue after surfactant treatment: effect of perflubron dose and ventilatory frequency.
    Wolfson MR; Kechner NE; Roache RF; DeChadarevian JP; Friss HE; Rubenstein SD; Shaffer TH
    J Appl Physiol (1985); 1998 Feb; 84(2):624-40. PubMed ID: 9475875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation.
    Laukemper-Ostendorf S; Scholz A; Bürger K; Heussel CP; Schmittner M; Weiler N; Markstaller K; Eberle B; Kauczor HU; Quintel M; Thelen M; Schreiber WG
    Magn Reson Med; 2002 Jan; 47(1):82-9. PubMed ID: 11754446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the development of choked flow during total liquid ventilation.
    Baba Y; Brant D; Brah SS; Grotberg J; Bartlett RH; Hirschl RB
    Crit Care Med; 2004 Jan; 32(1):201-8. PubMed ID: 14707580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. End-expiratory lung volumes and density distribution patterns during partial liquid ventilation in healthy and oleic acid-injured sheep: a computed tomography study.
    Luecke T; Meinhardt JP; Herrmann P; Klemm S; Weiss A; Weisser G; Hirschl RB; Quintel M
    Crit Care Med; 2003 Aug; 31(8):2190-7. PubMed ID: 12973179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perflubron decreases inflammatory cytokine production by human alveolar macrophages.
    Thomassen MJ; Buhrow LT; Wiedemann HP
    Crit Care Med; 1997 Dec; 25(12):2045-7. PubMed ID: 9403756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial liquid ventilation.
    Hamilton MC; Peek GJ; Dux AE
    Pediatr Radiol; 2005 Nov; 35(11):1152-6. PubMed ID: 16151790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.
    Noveck RJ; Shannon EJ; Leese PT; Shorr JS; Flaim KE; Keipert PE; Woods CM
    Anesth Analg; 2000 Oct; 91(4):812-22. PubMed ID: 11004031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of nosocomial pneumonia is not increased during partial liquid ventilation.
    Sajan I; Scannapieco FA; Fuhrman BP; Steinhorn DM
    Crit Care Med; 1999 Dec; 27(12):2741-7. PubMed ID: 10628620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial liquid ventilation with low dose of perflubron and a low stretch ventilation strategy improves oxygenation in a rabbit model of surfactant depletion.
    Nakamura T; Tamura M
    Biol Neonate; 2002; 82(1):66-9. PubMed ID: 12119544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid ventilation.
    Kaisers U; Kelly KP; Busch T
    Br J Anaesth; 2003 Jul; 91(1):143-51. PubMed ID: 12821573
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury.
    Curtis SE; Peek JT; Kelly DR
    J Appl Physiol (1985); 1993 Dec; 75(6):2696-702. PubMed ID: 8125892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome.
    Smith KM; Mrozek JD; Simonton SC; Bing DR; Meyers PA; Connett JE; Mammel MC
    Crit Care Med; 1997 Nov; 25(11):1888-97. PubMed ID: 9366775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers.
    Leese PT; Noveck RJ; Shorr JS; Woods CM; Flaim KE; Keipert PE
    Anesth Analg; 2000 Oct; 91(4):804-11. PubMed ID: 11004030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of pulmonary hypertension and hypoxia due to oleic acid induced lung injury with intratracheal prostaglandin E1 during partial liquid ventilation.
    Nakazawa K; Uchida T; Matsuzawa Y; Yokoyama K; Makita K; Amaha K
    Anesthesiology; 1998 Sep; 89(3):686-92. PubMed ID: 9743406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfluorooctyl bromide (perflubron) stimulates mucin secretion in the ferret trachea.
    Kishioka C; Dorighi MP; Rubin BK
    Chest; 1999 Mar; 115(3):823-8. PubMed ID: 10084498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Assessment of Partial Liquid Ventilation in Bronchopulmonary Dysplasia.
    Degnan AJ; Zhu X; Flowers C; Fox WW; Zhang H; Saul D
    Curr Probl Diagn Radiol; 2019; 48(3):247-250. PubMed ID: 30738593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pressure increase due to hydrostatic pressure of perfluorocarbon.
    Roemer WM; Gentzsch S; Andel H
    Am J Respir Crit Care Med; 2006 May; 173(9):1046; author repply 1046-7. PubMed ID: 16632636
    [No Abstract]   [Full Text] [Related]  

  • 39. Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems.
    Rotta AT; Gunnarsson B; Fuhrman BP; Wiryawan B; Hernan LJ; Steinhorn DM
    Pediatr Crit Care Med; 2003 Apr; 4(2):233-8. PubMed ID: 12749658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the application of liquid ventilation].
    Xie LX; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):730-3. PubMed ID: 18218199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.